Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Novel Approvals Grew To 60 In 2021; CDER Cleared 50 New Agents, Turned Down 18
Jan 02 2022
•
By
Bridget Silverman
CDER’S APPROVAL LIFT IN 2021 WAS EVEN MORE WEIGHTED TOWARD PRIORITY REVIEWS THAN USUAL. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approvals
More from Product Reviews